{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:00:45Z","timestamp":1792839645053,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","gastrojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1053\/j.gastro.2016.01.004","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T21:00:42Z","timestamp":1452718842000},"page":"1160-1170.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":283,"title":["Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis"],"prefix":"10.1053","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3421-937X","authenticated-orcid":false,"given":"Juan G.","family":"Abraldes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candid","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Aracil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Turnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3478-9981","authenticated-orcid":false,"given":"Manuel","family":"Hernandez-Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0831-8422","authenticated-orcid":false,"given":"Joan","family":"Genesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Castellote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Garc\u00eda-Pag\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7355-7913","authenticated-orcid":false,"given":"Ferran","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustin","family":"Albillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elba","family":"Llop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia Morales","family":"Arraez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goretti","family":"Hern\u00e1ndez Mesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Reverter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Seijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Turon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Mi\u00f1ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Buenestado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Re\u00f1e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen A.","family":"Navacu\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Planas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Morillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Bellot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Such","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Puente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"de la Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Mera Calvi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rivas Moral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana","family":"Pavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edilmar","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Ardevol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Girbau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Cachero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Albert","family":"Arnaiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Berzigotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Pich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Saenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Millan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Beleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2016.01.004_bib1","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/gut.2008.171207","article-title":"Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicenter randomized controlled trial","volume":"58","author":"Garcia-Pagan","year":"2009","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2016.01.004_bib2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2015.05.011","article-title":"Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents vs hemodynamically controlled medical therapy","volume":"149","author":"Sauerbruch","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.01.004_bib3","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(95)91740-3","article-title":"Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis","volume":"346","author":"Feu","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2016.01.004_bib4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2004.01.017","article-title":"Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis","volume":"40","author":"Villanueva","year":"2004","journal-title":"JHepatol"},{"key":"10.1053\/j.gastro.2016.01.004_bib5","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/jhep.2003.50133","article-title":"Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis","volume":"37","author":"Abraldes","year":"2003","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.01.004_bib6","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/hep.25686","article-title":"Long-term follow-up of hemodynamic responders to pharmacological therapy after variceal bleeding","volume":"56","author":"Augustin","year":"2012","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.01.004_bib7","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2007.01.020","article-title":"Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats","volume":"46","author":"Abraldes","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.01.004_bib8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/hep.21673","article-title":"Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA\/Rho-kinase and activation of endothelial nitric oxide synthase","volume":"46","author":"Trebicka","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.01.004_bib9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2010.04.025","article-title":"Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells","volume":"53","author":"Trebicka","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.01.004_bib10","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.26127","article-title":"Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction","volume":"57","author":"La Mura","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.01.004_bib11","first-page":"A58","article-title":"Simvastatin prevents liver microvascular dysfunction and attenuates liver injury in rats with biliary cirrhosis submitted to hemorrhage\/resuscitation","author":"Meireles","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.01.004_bib12","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/gutjnl-2014-308338","article-title":"KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins","volume":"64","author":"Marrone","year":"2015","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2016.01.004_bib13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1053\/j.gastro.2003.12.007","article-title":"Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis","volume":"126","author":"Zafra","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.01.004_bib14","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1053\/j.gastro.2009.01.043","article-title":"Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial","volume":"136","author":"Abraldes","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.01.004_bib15","unstructured":"nQuery Advisor Version 6.01. Statistical Solutions, Cork, Ireland. 2010. Available at: http:\/\/www.statistical-solutions-software.com\/products-page\/nquery-advisor-sample-size-software\/. Accessed October 18,\u00a02011."},{"key":"10.1053\/j.gastro.2016.01.004_bib16","unstructured":"International Conference on Harmonization, ICH E9 Statistical principles for clinical trials (CPMP\/ICH\/363\/96). Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500002928.pdf. Accessed April 21,\u00a02013."},{"key":"10.1053\/j.gastro.2016.01.004_bib17","unstructured":"European Medicines Agency's guidelines on the clinical efficacy and safety of medicines. Available at: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl = pages\/regulation\/general\/general_content_000602.jsp&mid = WC0b01ac05807d91a4. Accessed Jun 11,\u00a02015."},{"key":"10.1053\/j.gastro.2016.01.004_bib18","doi-asserted-by":"crossref","first-page":"G147","DOI":"10.1152\/ajpgi.00462.2007","article-title":"Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver","volume":"296","author":"Moreno","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1053\/j.gastro.2016.01.004_bib19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","article-title":"Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"53","author":"de Franchis","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.01.004_bib20","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1007\/s10620-014-3179-2","article-title":"Statin use in patients with cirrhosis: a retrospective cohort study","volume":"59","author":"Kumar","year":"2014","journal-title":"Digest Dis Sci"},{"key":"10.1053\/j.gastro.2016.01.004_bib21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/apt.12430","article-title":"Statin use and infections in veterans with cirrhosis","volume":"38","author":"Motzkus-Feagans","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.01.004_bib22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1053\/j.gastro.2015.10.007","article-title":"Statins are associated with a decreased risk of decompensation and death in veterans with hepatitis C-related compensated cirrhosis","volume":"150","author":"Mohanty","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.01.004_bib23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep.27835","article-title":"Effect of addition of statins to antiviral therapy in HCV infected persons: results from ERCHIVES","volume":"62","author":"Butt","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.01.004_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jhep.2014.08.013","article-title":"Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C","volume":"62","author":"Simon","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.01.004_bib25","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1200\/JCO.2012.44.6831","article-title":"Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection","volume":"31","author":"Tsan","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1053\/j.gastro.2016.01.004_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/COPD.S76061","article-title":"Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial","volume":"10","author":"John","year":"2015","journal-title":"Int J Chron Obstruct Pulm Dis"},{"key":"10.1053\/j.gastro.2016.01.004_bib27","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1056\/NEJMoa1403086","article-title":"Simvastatin for the prevention of exacerbations in moderate-to-severe COPD","volume":"370","author":"Criner","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2016.01.004_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.20452\/pamw.869","article-title":"The influence of simvastatin on selected inflammatory markers in patients with chronic obstructive pulmonary disease","volume":"120","author":"Kaczmarek","year":"2010","journal-title":"Pol Arch Med Wewn"},{"key":"10.1053\/j.gastro.2016.01.004_bib29","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1403285","article-title":"Simvastatin in the acute respiratory distress syndrome","volume":"371","author":"McAuley","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2016.01.004_bib30","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1401520","article-title":"Rosuvastatin for sepsis-associated acute respiratory distress syndrome","volume":"370","author":"Truwit","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2016.01.004_bib31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1164\/rccm.201209-1718OC","article-title":"A\u00a0multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis","volume":"187","author":"Kruger","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.gastro.2016.01.004_bib32","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1001\/jama.2013.280031","article-title":"Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial","volume":"310","author":"Papazian","year":"2013","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2016.01.004_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12664-013-0420-4","article-title":"Randomized clinical trial: atorvastatin versus placebo in patients with acute exacerbation of mild to moderate ulcerative colitis","volume":"33","author":"Dhamija","year":"2014","journal-title":"Indian J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.01.004_bib34","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe","volume":"74","author":"Feldman","year":"2010","journal-title":"Neurology"},{"key":"10.1053\/j.gastro.2016.01.004_bib35","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0b013e318228bf11","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease","volume":"77","author":"Sano","year":"2011","journal-title":"Neurology"},{"key":"10.1053\/j.gastro.2016.01.004_bib36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S1474-4422(11)70144-2","article-title":"Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial","volume":"10","author":"Sorensen","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.gastro.2016.01.004_bib37","first-page":"2401","article-title":"Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial","volume":"259","author":"Kamm","year":"2012","journal-title":"J\u00a0Neurol"},{"key":"10.1053\/j.gastro.2016.01.004_bib38","doi-asserted-by":"crossref","first-page":"e86663","DOI":"10.1371\/journal.pone.0086663","article-title":"Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial","volume":"9","author":"Kamm","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2016.01.004_bib39","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1016\/j.ejca.2014.08.005","article-title":"Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: a double-blind randomised phase 3 study","volume":"50","author":"Kim","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.gastro.2016.01.004_bib40","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1158\/1940-6207.CAPR-13-0189","article-title":"A\u00a0randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology","volume":"7","author":"Linden","year":"2014","journal-title":"Cancer Prev Res"},{"key":"10.1053\/j.gastro.2016.01.004_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00280-013-2328-1","article-title":"Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients","volume":"73","author":"Hong","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/j.gastro.2016.01.004_bib42","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/1078-0432.CCR-10-2525","article-title":"A\u00a0randomized phase II study of gefitinib plus simvastatin versus gefitinib alone in previously treated patients with advanced non-small cell lung cancer","volume":"17","author":"Han","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.gastro.2016.01.004_bib43","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1016\/j.ejca.2010.07.036","article-title":"The addition of pravastatin to chemotherapy in advanced gastric carcinoma: a randomised phase II trial","volume":"46","author":"Konings","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.gastro.2016.01.004_bib44","series-title":"Portal Hypertension: Proceedings of the Fifth Baveno International Consensus Workshop","first-page":"46","article-title":"Clinical epidemiology and statistical challenges in defining, recording and analysing endpoints","author":"Andersen","year":"2011"},{"key":"10.1053\/j.gastro.2016.01.004_bib45","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2006.09.013","article-title":"Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review","volume":"131","author":"D'Amico","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.01.004_bib46","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients","volume":"39","author":"D'Amico","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.01.004_bib47","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/hep.24755","article-title":"Addition of simvastatin to cold storage solution prevents endothelial dysfunction in explanted rat livers","volume":"55","author":"Russo","year":"2012","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.01.004_bib48","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/heartjnl-2012-302014","article-title":"Predicting the adverse risk of statin treatment: an independent and external validation of Qstatin risk scores in the UK","volume":"98","author":"Collins","year":"2012","journal-title":"Heart"},{"key":"10.1053\/j.gastro.2016.01.004_bib49","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2016.01.004_bib50","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(10)60310-8","article-title":"Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial","volume":"376","author":"Armitage","year":"2010","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2016.01.004_bib51","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1111\/j.1530-0277.2012.01901.x","article-title":"Association of liver stiffness with hepatic expression of pharmacokinetically important genes in alcoholic liver disease","volume":"37","author":"Theile","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1053\/j.gastro.2016.01.004_bib52","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1124\/dmd.112.049676","article-title":"Alcohol cirrhosis alters nuclear receptor and drug transporter expression in human liver","volume":"41","author":"More","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1053\/j.gastro.2016.01.004_bib53","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy\u2014a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2016.01.004_bib54","doi-asserted-by":"crossref","first-page":"e1268","DOI":"10.1097\/MD.0000000000001268","article-title":"Association between SLCO1B1 gene T521C polymorphism and statin-related myopathy risk: a meta-analysis of case-control studies","volume":"94","author":"Hou","year":"2015","journal-title":"Medicine"},{"key":"10.1053\/j.gastro.2016.01.004_bib55","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00228-011-1125-1","article-title":"SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia","volume":"68","author":"Santos","year":"2012","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508516000433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508516000433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T23:51:19Z","timestamp":1748735479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508516000433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0016508516000433"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2016.01.004","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726079867.793525056","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.726079867.793513554","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.726079867.793513910","asserted-by":"object"}]},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2016.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The AGA Institute.","name":"copyright","label":"Copyright"}]}}